<DOC>
	<DOC>NCT01605331</DOC>
	<brief_summary>As studies demonstrate, the administration of recombinant human GH (rhGH) in adults with GH deficiency has been known to improve metabolic impairment and quality of life. Patients, however, do have to tolerate daily injections of GH (rhGH).</brief_summary>
	<brief_title>Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<criteria>Men and women aged â‰¥ 20 years with diagnosed GH deficiency (caused by pituitary tumor, trauma, other pituitary disease)</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Adults</keyword>
	<keyword>GH deficiency</keyword>
</DOC>